Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 192

1.

Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis.

Trinkley KE, Anderson HD, Nair KV, Malone DC, Saseen JJ.

Ther Adv Chronic Dis. 2018 Jun 13;9(9):179-190. doi: 10.1177/2040622318779760. eCollection 2018 Sep.

2.

Tolerability and clinical efficacy of inhaled treprostinil in patients with group 1 pulmonary arterial hypertension.

Enderby CY, Burger C.

Ther Adv Chronic Dis. 2018 Jun 3;9(9):171-177. doi: 10.1177/2040622318779749. eCollection 2018 Sep.

3.

Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy.

Ariëns LFM, Bakker DS, van der Schaft J, Garritsen FM, Thijs JL, de Bruin-Weller MS.

Ther Adv Chronic Dis. 2018 May 11;9(9):159-170. doi: 10.1177/2040622318773686. eCollection 2018 Sep. Review.

4.

Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experience.

Sator P.

Ther Adv Chronic Dis. 2018 Aug;9(8):147-158. doi: 10.1177/2040622318772705. Epub 2018 May 22. Review.

5.

An elderly patient's complete response to steroid therapy for collagenous gastritis.

Lim HW, Wong BY, Elkowitz D, Sultan K.

Ther Adv Chronic Dis. 2018 Aug;9(8):143-146. doi: 10.1177/2040622318759628. Epub 2018 Mar 19.

6.

Responsive brain stimulation in epilepsy.

Hartshorn A, Jobst B.

Ther Adv Chronic Dis. 2018 Jul;9(7):135-142. doi: 10.1177/2040622318774173. Epub 2018 May 7. Review.

7.

Carotid stenting with proximal cerebral protection in symptomatic low-grade vulnerable recurrent carotid stenosis.

de Haro J, Rodriguez-Padilla J, Bleda S, Cañibano C, Michel I, Acin F.

Ther Adv Chronic Dis. 2018 Jun;9(6):125-133. doi: 10.1177/2040622318765727. Epub 2018 Mar 27.

8.

Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept.

Rendina M, Castellaneta NM, Losurdo G, Castellaneta A, Cazzolla A, Chialà C, D'Errico F, Di Leo A.

Ther Adv Chronic Dis. 2018 Jun;9(6):121-123. doi: 10.1177/2040622318755651. Epub 2018 Feb 12. No abstract available.

9.

Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment.

Chan TC, Hawkes JE, Krueger JG.

Ther Adv Chronic Dis. 2018 May;9(5):111-119. doi: 10.1177/2040622318759282. Epub 2018 Mar 19.

10.

Time to reappraise the therapeutic place of celecoxib.

Beales ILP.

Ther Adv Chronic Dis. 2018 May;9(5):107-110. doi: 10.1177/2040622317749394. Epub 2018 Jan 3. No abstract available.

11.

Dealing with uncertainty in the treatment of Helicobacter pylori.

Calvet X.

Ther Adv Chronic Dis. 2018 Apr;9(4):93-102. doi: 10.1177/2040622318758240. Epub 2018 Feb 12. Review.

12.

New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.

Dubash S, McGonagle D, Marzo-Ortega H.

Ther Adv Chronic Dis. 2018 Mar;9(3):77-87. doi: 10.1177/2040622317743486. Epub 2017 Dec 14. Review.

13.

Acute severe ulcerative colitis: latest evidence and therapeutic implications.

Dulai PS, Jairath V.

Ther Adv Chronic Dis. 2018 Feb;9(2):65-72. doi: 10.1177/2040622317742095. Epub 2017 Nov 24. Review.

14.

Developments in rare bone diseases and mineral disorders.

Bacon S, Crowley R.

Ther Adv Chronic Dis. 2018 Jan;9(1):51-60. doi: 10.1177/2040622317739538. Epub 2017 Nov 24. Review.

15.

Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential.

Røder ME.

Ther Adv Chronic Dis. 2018 Jan;9(1):33-50. doi: 10.1177/2040622317735283. Epub 2017 Nov 9. Review.

16.

Management of functional dyspepsia: state of the art and emerging therapies.

Yamawaki H, Futagami S, Wakabayashi M, Sakasegawa N, Agawa S, Higuchi K, Kodaka Y, Iwakiri K.

Ther Adv Chronic Dis. 2018 Jan;9(1):23-32. doi: 10.1177/2040622317725479. Epub 2017 Aug 27. Review.

17.

Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.

Frieder J, Kivelevitch D, Menter A.

Ther Adv Chronic Dis. 2018 Jan;9(1):5-21. doi: 10.1177/2040622317738910. Epub 2017 Nov 16. Review.

18.

Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era.

Hammersley D, Signy M.

Ther Adv Chronic Dis. 2017 Dec;8(12):165-176. doi: 10.1177/2040622317720106. Epub 2017 Jul 26. Review.

19.

Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy.

Barshop K, Staller K.

Ther Adv Chronic Dis. 2017 Nov;8(11):153-160. doi: 10.1177/2040622317714389. Epub 2017 Jun 21. Review.

20.

Haemorrhoids: an update on management.

Brown SR.

Ther Adv Chronic Dis. 2017 Oct;8(10):141-147. doi: 10.1177/2040622317713957. Epub 2017 Jun 21. Review.

Supplemental Content

Loading ...
Support Center